Physician profile
Michael E Bertocchi
NPI 1972558518
$3,042.46
in general payments reported to CMS, 2019-2025
17 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $299 · 2021: $87.08 · 2022: $241 · 2023: $150 · 2024: $116 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,652 · Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,651.60 |
| Food and Beverage | $401.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,751.60 | 2025 | Other - Miscellaneous |
| Intuitive Surgical, INC. | $456.77 | 2019-2023 | Da Vinci Surgical System |
| Sanara Medtech INC. | $209.43 | 2022 | |
| Acell, INC. | $124.73 | 2020 | |
| Innovation Technologies INC | $85.43 | 2023-2024 | Irrisept |
| Medtronic, INC. | $74.17 | 2021 | |
| Organogenesis INC. | $51.40 | 2023 | Puraply |
| Davol INC. | $51.28 | 2019 | |
| Smith+Nephew, INC. | $41.72 | 2019-2021 | |
| Urgo Medical North America, LLC | $35.60 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Teleflex LLC | $35.29 | 2023-2024 | Deknatel, Weck |
| Edwards Lifesciences Corporation | $31.34 | 2022 | |
| Covidien LP | $24.81 | 2019 | |
| Reddress USA, INC. | $21.90 | 2024 | |
| Mimedx Group, INC. | $19.98 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $13.51 | 2023 | Matrixrib |
| Tela Bio, INC. | $13.50 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bertocchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.